Get the Stockscreener App
12.77
0.39%
-0.05
After Hours:
12.81
0.04
+0.31%
Dr Reddys Laboratories Ltd Adr stock is traded at $12.77, with a volume of 2.65M.
It is down -0.39% in the last 24 hours and up +7.31% over the past month.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$12.82
Open:
$12.92
24h Volume:
2.65M
Relative Volume:
0.84
Market Cap:
$10.64B
Revenue:
$3.81B
Net Income/Loss:
$485.75M
P/E Ratio:
21.74
EPS:
0.5873
Net Cash Flow:
$175.50M
1W Performance:
+2.24%
1M Performance:
+7.31%
6M Performance:
-3.77%
1Y Performance:
-11.07%
1-Day Range:
$12.74
$12.95
1-Week Range:
$11.99
$12.99
52-Week Range:
$11.36
$15.67
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
12.77 | 10.64B | 3.81B | 485.75M | 175.50M | 0.5873 |
TAK
Takeda Pharmaceutical Co Adr
|
18.52 | 59.16B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.25 | 48.11B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.44 | 41.51B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
74.30 | 30.70B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
543.40 | 23.31B | 3.17B | 1.29B | 1.01B | 27.09 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-26 | Upgrade | Citigroup | Sell → Buy |
| Apr-23-26 | Downgrade | Goldman | Neutral → Sell |
| Jun-05-25 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-19-24 | Downgrade | Nomura | Buy → Neutral |
| Jan-11-24 | Downgrade | Jefferies | Buy → Underperform |
| Aug-29-23 | Downgrade | HSBC Securities | Buy → Hold |
| May-18-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-17-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-30-23 | Initiated | JP Morgan | Underweight |
| Nov-14-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Jan-03-22 | Resumed | BofA Securities | Neutral |
| Jul-27-21 | Downgrade | Credit Suisse | Outperform → Neutral |
| Feb-02-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-18-20 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-18-20 | Upgrade | Investec | Sell → Hold |
| Jan-28-20 | Downgrade | CLSA | Buy → Outperform |
| Jan-27-20 | Downgrade | CLSA | Buy → Outperform |
| Jan-09-20 | Upgrade | Citigroup | Sell → Buy |
| Nov-04-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-04-19 | Upgrade | Credit Suisse | Underperform → Outperform |
| Jul-01-19 | Upgrade | Macquarie | Neutral → Outperform |
| Jun-20-19 | Initiated | Deutsche Bank | Hold |
| Jun-11-19 | Initiated | Barclays | Equal Weight |
| May-20-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-19-19 | Upgrade | CLSA | Outperform → Buy |
| Jan-17-19 | Downgrade | Citigroup | Neutral → Sell |
| Sep-21-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-31-17 | Upgrade | CLSA | Underperform → Outperform |
| Jul-28-17 | Downgrade | CLSA | Underperform → Sell |
| Jul-27-16 | Downgrade | HSBC Securities | Hold → Reduce |
| Jul-27-16 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-16 | Upgrade | Credit Agricole | Underperform → Buy |
| Nov-10-15 | Downgrade | Citigroup | Buy → Neutral |
View All
Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News
Top Stock Reports for Oracle, American Express & Progressive - Zacks Investment Research
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Yahoo Finance
Pomerantz LLP investigates Dr. Reddy's over semaglutide-linked losses - scanx.trade
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Flat - Yahoo Finance
Global Substance Use Disorder Treatment Market Analysis and Forecast to 2030 | Long-Acting Therapies, Telemedicine, and Drug Innovation Drive Growth - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - finance.yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo! Finance Canada
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down for Week - Yahoo Finance
HDFC Bank Limited (HDB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wipro Limited (WIT) Stock Price, News, Quote & History - Yahoo! Finance Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy’s Laboratories LimitedRDY - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - Yahoo Finance
Dr. Reddy's probed for fraud after ₹2.4bn semaglutide hit - scanx.trade
Dr Reddy's Laboratories stock gains attention on QDENGA vaccine deal - AD HOC NEWS
Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up Marginally for Week - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading - Yahoo Finance
Dr. Reddy's faces fifth US securities probe after semaglutide hit - scanx.trade
Asian Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - finance.yahoo.com
Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise - TipRanks
Dr. Reddy’s (NYSE: RDY) adds 375 shares via employee options - Stock Titan
Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - Yahoo Finance
Dr. Reddy's Laboratories (RDY) Holds at $11.9 as Shares Consolidate Between Key LevelsPCR Mean Reversion - siam.in
Dr. Reddy’s ADR tests $11.70 support after bearish close: Live levels - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Yahoo Finance
Dr. Reddy’s ADR tests key support 4th time: Live levels By Investing.com - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - Yahoo Finance
GLP-1 sales in Canada on pace to set a new record this year - The Globe and Mail
Dr. Reddy’s (NYSE: RDY) issues 4,110 stock-option shares - Stock Titan
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Yahoo Finance
Dr. Reddy’s Labs ADR trapped in no-trade zone: Live levels - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading - Yahoo Finance
Dr. Reddy’s ADR tests ₹12.00 support: Live levels By Investing.com - Investing.com India
symbol__ Stock Quote Price and Forecast - CNN
ETFs Investing in Dr. Reddy's Laboratories Ltd. Sponsored ADR Stocks - TradingView
Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Yahoo Finance
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - Yahoo Finance
Dr. Reddy’s ADR bear flag 80% complete: Live levels By Investing.com - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - Yahoo Finance
Dr. Reddy’s Labs ADR tests 50 SMA with doji: Live levels - Investing.com India
ETFs Investing in Dr. Reddy's Laboratories Ltd. Sponsored ADR Stocks - TradingView
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):